Investment and M&A transaction comps
CPG Investment & M&A Transaction Comps
Global CPG and consumer brand investments, capital raises and M&A transactions, including food, beverage, beauty, personal care, supplements and adjacent branded consumer categories.
| Year | Transactions | Priced | Median EV or valuation / revenue | Median EV or valuation / EBITDA |
|---|---|---|---|---|
| 2026 | 50 | 21 | 4.1x | 9.9x |
| 2025 | 28 | 26 | 3.3x | 12.9x |
| 2024 | 24 | 23 | 3.1x | 16.0x |
| 2023 | 31 | 26 | 3.9x | 20.4x |
| 2022 | 26 | 17 | 3.6x | 20.4x |
| 2021 | 47 | 37 | 4.4x | 15.0x |
| 2020 | 34 | 25 | 4.5x | 14.7x |
| 2019 | 17 | 15 | 3.6x | 17.4x |
Sortable transaction comps
CPG transaction table
Rows with reported value
1 / 1
Acquisition EV, USD
USD 2.6B
Investment EV, USD
-
Median EV / revenue
4.4x
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
1 shown of 1 matching transactions. Click any transaction row for more detail.
Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately, and a financing without a reported valuation shows its amount raised, not an EV.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Cooper Consumer Health Control | 2021-03-12 | CVC Capital Partners and Avista | EUR 2.2B Consideration | 2,611 | 4.4x | 14.2x | France & Europe | Estimated 1 source |